The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLERGAN PLC | SHS | G0177J108 | 38,229 | 199,973 | SH | SOLE | 187,131 | 12,842 | 0 | ||
ALTISOURCE ASSET MGMT CORP | COM | 02153X108 | 659 | 53,321 | SH | SOLE | 53,321 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 5,234 | 1,738,723 | SH | SOLE | 1,596,141 | 142,582 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 706 | 9,500 | SH | Call | SOLE | 8,800 | 700 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 1,927 | 25,934 | SH | SOLE | 25,934 | 0 | 0 | ||
HP INC | COM | 40434L105 | 1,233 | 60,000 | SH | SOLE | 54,070 | 5,930 | 0 | ||
INSTRUCTURE INC | COM | 45781U103 | 1,668 | 34,606 | SH | SOLE | 31,172 | 3,434 | 0 | ||
MEDICINES CO | COM | 584688105 | 16,096 | 189,500 | SH | SOLE | 179,716 | 9,784 | 0 | ||
MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 732 | 6,250 | SH | SOLE | 5,914 | 336 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 20,406 | 603,714 | SH | SOLE | 550,911 | 52,803 | 0 | ||
TIFFANY & CO NEW | COM | 886547108 | 34,323 | 256,814 | SH | SOLE | 245,242 | 11,572 | 0 | ||
ZAYO GROUP HLDGS INC | COM | 98919V105 | 33,328 | 961,842 | SH | SOLE | 914,086 | 47,756 | 0 |